Heart failure trials in Peru
4 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleEfficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Where
- Jesús María, San Borja
- Age
- 29 days to 17 years
- People
- 342 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05714085 · EU 2022-501238-52-00 - Phase 3Taking peoplePhase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Where
- Bellavista, Callao, Chorrillos, Cusco, Lima, Piura
- Age
- 40 years and over
- People
- 11,300 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00 - Phase 3Taking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Bellavista, Cusco, Lima, Piura
- Age
- 18 years to 130 years
- People
- 3,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - Phase 3Taking peopleA Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Where
- Lima
- Age
- 18 years and over
- People
- 5,200 worldwide
- Run by
- Colorado Prevention Center
See details and how to joinNCT06008197